Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q2 FY27
Investor Presentation
Q2 FY27
Investor Presentation
Q4 FY25
Investor Presentation
Q4 FY25
Investor Presentation
Q4 FY25
Bearish
3
Neutral
3
Bullish
8
Bearish
27
Neutral
3
Bullish
16
Bearish
24
Neutral
0
Bullish
8
Bearish
3
Neutral
3
Bullish
8
Bearish
3
Neutral
3
Bullish
8
Bearish
24
Neutral
0
Bullish
8
Bearish
24
Neutral
0
Bullish
8
Bearish
24
Neutral
0
Bullish
8
Pharmaceuticals & Biotechnology
Pharmaceuticals
1,421 Cr
Low Risk
25.0
34.8
0.6
5.2
731.70
253.00
Sales CAGR
Profit CAGR
ROE
ROCE
Accent Microcell Ltd (ACCENTMIC) is currently trading at 592.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Accent Microcell Limited manufactures pharmaceutical excipients, principally Microcrystalline Cellulose (MCC) and premium co‑processed grades, serving pharmaceutical, nutraceutical, food, cosmetic and certain industrial customers through two operating plants in Gujarat and a specialty Unit III under commissioning. H1 FY27 showed sharply improved operating performance: revenue of ₹174.8 crore (▲25% YoY), EBITDA margin of 25.11% (▲609 bps YoY) and PAT of ₹31.1 crore (▲72% YoY), driven by premium mix expansion, higher export share and operating leverage while maintaining a near net‑cash balance sheet. Accent has shifted its product mix toward premium specialty excipients: premium product share rose to 13.52% and export revenue was 72.34% in H1 FY27, reflecting successful qualification efforts and the company’s EXCiPACT, US‑DMF and multi‑certification stack that supports China+1 demand from regulated‑market customers. Unit III is the strategic inflection: Phase‑1 targets CCS, SSG and pulp‑based CMC with ~₹70 crore year‑1 revenue potential and realisations of ₹650–700/kg, while Phase‑2 plans a large MCC expansion raising the company’s long‑term capacity runway and expected higher average realisations and margins.
Over the past 52 weeks, Accent Microcell Ltd has traded between a low of ₹253.00 and a high of ₹731.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Accent Microcell Ltd has a market capitalization of approximately 1,421.35. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Accent Microcell Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.98 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,421.35 Cr, Accent Microcell Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Accent Microcell Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Accent Microcell Ltd is 24.98. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
